A few short line posts may not seem significant at first glance. However, if one pauses and evaluates them carefully, they may suggest a potentially game-changing scientific question (link).
There have been reports of making ivermectin available for cancer treatment, including in certain jurisdictions such as Florida. This is noteworthy because ivermectin is not a cancer drug. It is a well-known antiparasitic medication, developed and historically used to treat parasitic infections in both humans and animals. That is its established and documented purpose.
More recently, however, some have promoted ivermectin as having potential anti-cancer effects. At the same time, mainstream medical experts and regulatory agencies have not accepted this claim as established therapy and do not endorse its routine use for cancer treatment.
This situation invites a broader scientific question.
Cancer, as commonly defined, is primarily diagnosed through histological observation, imaging, and pathological interpretation. While these are established medical practices, the definition of cancer remains largely descriptive — based on cellular morphology and growth behavior — rather than on a single, universally defined physicochemical parameter.
If a drug known for its antiparasitic activity were to demonstrate reproducible benefit in certain cancer contexts, one possible interpretation could be that it acts through mechanisms unrelated to traditional cytotoxic (cancer) chemotherapy — perhaps through inflammation pathways or other biological processes. Such findings would not automatically redefine cancer as a parasitic disease. However, they would warrant careful scientific investigation into underlying mechanisms.
It is important to be clear: there is currently no established scientific consensus that cancer is a parasitic illness, nor that ivermectin is a proven cancer treatment. Nonetheless, unconventional findings sometimes prompt re-examination of existing models. That re-examination, if undertaken, must be rigorous, controlled, and grounded in measurable and reproducible evidence.
If there are signals suggesting unexpected therapeutic effects, they deserve systematic study—not dismissal. True scientific assessment requires careful definition, transparent methodology, and independent verification.
Questions of this magnitude should not be resolved by enthusiasm or rejection alone, but by disciplined scientific inquiry.
Ivermectin And Cancer (link).